My first line of questioning will go toward VIDO-InterVac and Dr. Paul Hodgson.
In his presentation. Dr. Gerdts talked about the development of the 10 vaccines that your organization has developed so far, one being for pigs. It took 18 months to get that vaccine, but it is currently out there and being used.
I want to talk a bit more about the mechanics of who owns the rights to these vaccines and who will have access. I know this was asked earlier by a few others, but I would like some further clarification.
If a company like yours develops a vaccine, is this a licence to print money, or are there regulations about how it can be sold and how it can be distributed? Are there any international agreements or is there a framework in place for the sharing and the distribution of these future vaccines? Will there be a mad rush from all nations, or is there an orderly distribution process to follow? There are a number of questions here in anticipation of a vaccine being developed.
If a company such as yours develops this vaccine here in Canada, is it up to the—